Under the direction of Executive Director Walter J. Curran, Jr., MD, Winship has continued to enhance its administrative team and its functionality through process improvements, staff restructuring, and growth. Senior Director for Cancer Research Administration Kimberly Kerstann, PhD oversees Winship Administration. Kerstann sets the Winship administrative priorities to facilitate the strategic advancement of collaborative cancer- related research in a matrix organization. Winship Administration assists the Executive Director, senior leadership, program leaders and co-leaders, shared resource directors, and members in fulfilling the mission of Winship by offering highly effective administrative management, program planning, and centralized services. The administrative unit supports faculty and staff involved with the CCSG and its related activities, occupants of Winship space, recipients of Winship pilot grants and philanthropic funds, participants in cancer disease site working groups and programs, and participants in clinical oncology investigation. Winship Administration has continued to seek guidance from internal and external advisors and act strategically to position itself for growth. Winship?s senior leadership team is comprised of Executive Director Walter J. Curran, Jr., MD; Deputy Director Suresh Ramalingam, MD; Associate Director for Population Sciences Carla Berg, PhD; Associate Director for Mentorship, Education, and Training Deborah Bruner, PhD, RN; Associate Director for Basic Science Paul Doetsch, PhD; Associate Director for Clinical Research Bassel El-Rayes, MD; and Senior Director for Cancer Research Administration Kimberly Kerstann, PhD. Senior leadership oversees the advancement of Winship?s scientific priorities, Winship?s research programs and shared resources, Winship?s education, training, and mentorship efforts, Winship?s multi-investigator, multi-disciplinary, and translational science, and its cancer- related clinical research. Senior leadership is also responsible for developing and executing Winship?s strategic planning process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA138292-09
Application #
9280108
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
9
Fiscal Year
2017
Total Cost
$515,670
Indirect Cost
$186,299
Name
Emory University
Department
Type
Domestic Higher Education
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M et al. (2018) Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer 124:775-784
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain Behav Immun 74:291-295
Jhaveri, Jaymin; Rayfield, Lael; Liu, Yuan et al. (2018) Impact of intensity modulated radiation therapy on survival in anal cancer. J Gastrointest Oncol 9:618-630
Jhaveri, Jaymin; Chowdhary, Mudit; Zhang, Xinyan et al. (2018) Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. J Neurosurg :1-7
Chowdhary, Mudit; Switchenko, Jeffrey M; Press, Robert H et al. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol 139:689-697
Bilen, Mehmet Asim; Dutcher, Giselle Marie Almeida; Liu, Yuan et al. (2018) Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer 16:e563-e575
Morgan, T M; Wang, X; Qian, X et al. (2018) Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes. Clin Transl Oncol :
Lin, Songbai; Han, Yiran; Jenkin, Kayte et al. (2018) Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis. Am J Pathol 188:353-366
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Bekhbat, Mandakh; Chu, Karen; Le, Ngoc-Anh et al. (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222-229

Showing the most recent 10 out of 331 publications